Clinical Cancer Drugs

Publisher： Bentham Science Publishers

Founded in： 2014

Total resources： 9

ISSN： 2212-697X

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Clinical Cancer Drugs

Menu

Evaluation of Antitumor Potential of Forskolin and Andrographolide Employing Potato Tumor Bioassay Model

Clinical Cancer Drugs , Vol. 3, Iss. 2, 2016-10 , pp. 121-130

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Graphical Abstracts:

Clinical Cancer Drugs , Vol. 3, Iss. 2, 2016-10 , pp. i-iii

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Efficacy of Bacteria in Cancer Immunotherapy: Special Emphasis on the Potential of Mycobacterial Species

Clinical Cancer Drugs , Vol. 3, Iss. 2, 2016-10 , pp. 100-108

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Meet Our Editor-in-Chief:

Clinical Cancer Drugs , Vol. 3, Iss. 2, 2016-10 , pp. 75-75

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Transforming Mutations of Jak3 (A573V and M511I) Show Differential Sensitivity to Selective Jak3 Inhibitors

Clinical Cancer Drugs , Vol. 3, Iss. 2, 2016-10 , pp. 131-137

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Tumor-selective Cytotoxicity of a Novel Pentadiene Analogue on Human Leukemia/lymphoma Cells

Clinical Cancer Drugs , Vol. 3, Iss. 2, 2016-10 , pp. 138-146

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Efficacy of Therapy with c-Met/HGF Inhibitors in Solid Tumors: A Systematic Review Based on 24 Clinical Trials

Clinical Cancer Drugs , Vol. 3, Iss. 2, 2016-10 , pp. 87-99

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Ameliorated Chemotherapeutic Potential of Diverse Dose Flouropyrimidine Therapy By Etodolac via NF-ΚB Pathway, PPAR-γ Expression and COX-II Inhibition in DMH Induced Colon Cancer Rats

Clinical Cancer Drugs , Vol. 3, Iss. 2, 2016-10 , pp. 109-120

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

ACKNOWLEDGEMENTS TO REVIEWERS:

Clinical Cancer Drugs , Vol. 3, Iss. 2, 2016-10 , pp. 147-147

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors

Clinical Cancer Drugs , Vol. 3, Iss. 2, 2016-10 , pp. 76-86

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Previous 1 2 3 4 5 6 Next Display item(s) per page Total 58 item(s)